Vitiligo
231
24
38
95
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
22 trials with published results (10%)
Research Maturity
95 completed trials (41% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
6.9%
16 terminated out of 231 trials
85.6%
-1.0% vs benchmark
14%
32 trials in Phase 3/4
23%
22 of 95 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 95 completed trials
Clinical Trials (231)
The Value of Methotrexate in NCES for Stable Vitiligo
Assessment of Vitiligo Lesions Using Polarized Dermoscopy, Sub-Ultraviolet Reflectance Dermoscopy, and Ultraviolet Dermoscopy
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Topical Delgocitinib for Facial Vitiligo
Vitiligo Registry for Adults and Children in the UK
An Observational Study of Patients With Dermatologic Disease
Exosomal Markers CD63 and CD9 in Vitiligo Before and After NB-UVB Therapy
Oral Mini Pulse Dexamethasone in Pediatric Vitiligo
A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo
PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo
Study of D-2570 in Subjects With Non-Segmental Vitiligo
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
Defining the Role of the Skin Microbiome in Immune-related Adverse Events
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
Excimer Lamp Versus Excimer Laser in Vitiligo Treatment
A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo
Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
The Gut and Skin Microbiome in Vitiligo Disease Progression